tirzepatide is fda approved for obesity Breaking News: Approves Treating FDA Approves Diabetes Drug Tirzepatide – FDA says the tirzepatide weight-loss

It should not be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

You may also want to consider long-acting reversible contraception like the implant or coil

The overlap matters because it means you could trigger the same discontinuation-level side effects at a lower nominal dose simply by injecting more frequently

Rotate injection sites with each dose to prevent lipodystrophy and ensure consistent absorption

Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the publics health and share lifesaving resources